Welcome to our dedicated page for Corebridge Financial SEC filings (Ticker: CRBD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Corebridge Financial's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Corebridge Financial's regulatory disclosures and financial reporting.
Corebridge Financial, Inc. has scheduled its 2026 annual meeting of stockholders for September 16, 2026 at 9:00 a.m. Eastern Time. Stockholders of record at the close of business on July 28, 2026 will be entitled to vote at the meeting.
Because the meeting date is more than thirty days after the 2025 meeting, deadlines for stockholder submissions have changed. Proposals for inclusion in the 2026 proxy statement under Rule 14a-8 must be received by July 24, 2026. Under the Company’s proxy access by-laws, qualifying stockholders may submit director nominees for inclusion in the proxy materials by July 11, 2026.
Other stockholder proposals or director nominations to be presented at the 2026 annual meeting but not included in the proxy statement, and notices required under the universal proxy rules, must also be delivered by July 11, 2026.
Corebridge Financial, Inc. files a joint proxy statement/prospectus proposing an all-stock merger with Equitable Holdings to form New Equitable, subject to the terms and conditions of the Merger Agreement. Under the agreement, each share of Corebridge common stock will convert into 1.000 share of New Equitable common stock and each share of Equitable common stock will convert into 1.55516 shares of New Equitable common stock. New Equitable is described as having $1.5 trillion in assets under management and administration across its combined businesses. Corebridge stockholders and Equitable stockholders will vote virtually on July 30, 2026; approvals of each company’s merger proposal are conditions to closing. The joint proxy includes governance, preferred‑stock conversion mechanics, employee plan treatments, pro forma combined financial information and risk factors; directors of both companies unanimously recommend that their stockholders vote "FOR" the merger.
Colberg Alan B. reported acquisition or exercise transactions in this Form 4 filing.
Corebridge Financial director Alan B. Colberg reported an equity award of 6,553 deferred stock units (DSUs) of common stock. The DSUs were granted under the Corebridge Financial, Inc. 2022 Omnibus Incentive Plan at no cash price and are exempt under Rule 16b-3.
Following this grant, Colberg holds 64,962 shares in total, including 34,962 DSUs. Each DSU represents the right to receive one share of Corebridge common stock when his board service ends, linking a portion of his compensation to future company performance.
Schioldager Amy L. reported acquisition or exercise transactions in this Form 4 filing.
Corebridge Financial, Inc. director Amy L. Schioldager reported an equity compensation award in the form of deferred stock units (DSUs). She received 6,553 DSUs on common stock at a grant price of $0.00 per unit under the Corebridge Financial, Inc. 2022 Omnibus Incentive Plan.
Each DSU represents the right to receive one share of Corebridge common stock upon her termination of board service. Following this grant, her reported holdings total 34,962 DSUs, reflecting her accumulated director equity compensation in deferred form.
Parris Colin J. reported acquisition or exercise transactions in this Form 4 filing.
Corebridge Financial, Inc. director Colin J. Parris received a stock-based award in the form of deferred stock units (DSUs). On June 18, 2026, he was granted 6,553 DSUs at a stated price of $0.00 per unit under the Corebridge Financial, Inc. 2022 Omnibus Incentive Plan, exempt under Rule 16b-3. Each DSU represents the right to receive one share of Corebridge common stock when his board service ends. Following this grant, Parris holds a total of 13,894 DSUs, which track an equivalent number of common shares but generally do not settle until his termination of service.
Lynch Christopher S. reported acquisition or exercise transactions in this Form 4 filing.
Corebridge Financial, Inc. director Christopher S. Lynch received an award of 6,553 deferred stock units (DSUs) of common stock as a compensation grant. The DSUs were issued at no cash cost and increase his holdings to 34,962 DSUs, each convertible into one share when his board service ends.
Corebridge Financial director Deborah R. Leone received an equity award rather than trading shares on the market. On this Form 4, she acquired 6,553 shares of common stock in the form of deferred stock units (DSUs) granted under the Corebridge Financial, Inc. 2022 Omnibus Incentive Plan at a grant price of $0.00 per share. After this grant, she holds 19,136 DSUs, each representing the right to receive one share of Corebridge common stock when her board service ends. This is a routine compensation-related award exempt under Rule 16b-3.
Bousa Edward Peter reported acquisition or exercise transactions in this Form 4 filing.
Corebridge Financial, Inc. director Edward Peter Bousa received an equity award of 6,553 deferred stock units on June 18, 2026. The award was granted at a price of $0.00 per unit under the Corebridge Financial, Inc. 2022 Omnibus Incentive Plan. Each DSU represents a right to receive one share of common stock upon his termination of service as a director. Following this grant, Bousa holds a total of 16,852 DSUs, reflecting his accumulated stock-based board compensation rather than an open-market share purchase.
Gubbay Keith reported acquisition or exercise transactions in this Form 4 filing.
Corebridge Financial director Keith Gubbay received an equity award in the form of deferred stock units. He was granted 6,553 deferred stock units (DSUs) of Corebridge Financial, Inc. common stock under the 2022 Omnibus Incentive Plan, increasing his holdings to 13,894 DSUs. Each DSU represents one share, deliverable when his board service ends, and the grant was made at no cash cost to him as a compensation award rather than an open-market purchase.
Corebridge Financial, Inc. discussed progress on its proposed combination with Equitable Holdings, describing integration planning, leadership appointments and expected benefits tied to expense and revenue synergies.
Management reiterated a $500 million expense-synergy target (~30% in year 1, ~75% by year 2), said $90+ billion of assets are expected to flow to AllianceBernstein, and projected full-year VII returns around 1%–2%. Management highlighted cross‑sell, distribution scale, pension risk transfer activity of $4–5 billion and planned $50–70 million of incremental technology and AI spend.